Yasushige Akada
Mochida Pharmaceutical Co., Ltd
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Yasushige Akada.
Journal of Cardiovascular Pharmacology | 1993
Masami Sato; Yukio Katsuki; Hideo Kanehiro; Midori Iimura; Yasushige Akada; Masahiro Mizota; Yasuyuki Kunihiro
The effects of ethyl all-cis-5,8,11,14,17-icosapentaenoate (EPA-E) on in vivo physical properties of arteriosclerotic aorta and femoral artery in high cholesterol diet (HCD)-fed rabbits were studied. The aortic pulse wave velocity (PWV) of rabbits fed HCD for 12 weeks (control group) tended to be higher than that of rabbits fed a normal diet (normal group). Because the PWVs in HCD-fed rabbits administered orally with 30 and 300 mg/kg/day EPA-E were significantly lower than the PWV of the control group, the distensibility of arteriosclerotic aorta was improved with administration of EPA-E. The stiffness parameter (β) value as an in vivo indicator of arteriosclerosis was significantly higher in the control group than in the normal group and improved with administration of EPA-E to almost the same level as that of the normal group. The β-values were in significant negative correlation with medial elastin content and medial smooth muscle cell (SMC) density in thoracic aorta and in positive correlation with the free cholesterol content in abdominal aortic SMC. On the other hand, they were not correlated with either the cross-sectional area of intimal thickening lesions or the plasma lipid levels measured simultaneously. The femoral PWVs were, like those in the aorta, higher in the control group as compared with the normal group, and the changes were improved with administration of EPA-E. These results show that EPA-E improved the in vivo distensibility of arteriosclerotic arteries in HCD-fed rabbits. The mechanism of this improvement with EPA-E appeared to be related to histologic amelioration in the aortic medial elastic fibers and SMC and to protection from free cholesterol accumulation in SMC as one of the probable causes.
European Journal of Pharmacology | 2006
Yasushige Akada; Shinichi Ogawa; Ken-ichi Amano; Yuka Fukudome; Fumiaki Yamasaki; Manabu Itoh; Ichiro Yamamoto
Archive | 1997
Ichiro Yamamoto; Manabu Itoh; Masato Shimojo; Yasunobu Yumiya; Takafumi Mukaihira; Yasushige Akada
Archive | 2001
Ichiro Yamamoto; Manabu Itoh; Fumiaki Yamasaki; Yasushige Akada; Yutaka Miyazaki; Shinichi Ogawa
Archive | 2003
Yasushige Akada; Kazuyuki Matsuura
European Journal of Pharmacology | 2005
Yasushige Akada; Reiko Mori; Yutaka Kato; Fumiaki Yamasaki; Hidenori Mochizuki
Archive | 2000
Ichiro Yamamoto; Manabu Itoh; Fumiaki Yamasaki; Yasushige Akada; Yutaka Miyazaki; Shinichi Ogawa
Japanese Journal of Pharmacology | 1997
Hideyuki Funato; Hiroyuki Kawano; Yasushige Akada; Yukio Katsuki; Masami Sato; Akio Uemura
Archive | 2006
Hideharu Uchida; Naoto Kosuga; Tsutomu Satoh; Daido Hotta; Tomoyuki Kamino; Yoshitaka Maeda; Ken-ichi Amano; Yasushige Akada
Archive | 2002
Ichiro Yamamoto; Kazuyuki Matsuura; Kazuhiro Suzuki; Kazuo Kato; Yasushige Akada; Hidenori Mochizuki; Akihito Shimoi